X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA J.B.CHEMICALS ALEMBIC PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 16.8 17.3 96.8% View Chart
P/BV x 3.7 2.2 167.2% View Chart
Dividend Yield % 1.0 0.5 193.8%  

Financials

 ALEMBIC PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
J.B.CHEMICALS
Mar-18
ALEMBIC PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs664363 182.9%   
Low Rs412255 161.7%   
Sales per share (Unadj.) Rs208.7169.1 123.4%  
Earnings per share (Unadj.) Rs31.016.6 186.7%  
Cash flow per share (Unadj.) Rs37.123.4 158.5%  
Dividends per share (Unadj.) Rs5.502.00 275.0%  
Dividend yield (eoy) %1.00.6 157.9%  
Book value per share (Unadj.) Rs144.2172.5 83.6%  
Shares outstanding (eoy) m188.5283.57 225.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.61.8 141.1%   
Avg P/E ratio x17.418.6 93.3%  
P/CF ratio (eoy) x14.513.2 109.9%  
Price / Book Value ratio x3.71.8 208.3%  
Dividend payout %17.712.0 147.3%   
Avg Mkt Cap Rs m101,46125,827 392.8%   
No. of employees `000NA3.8 0.0%   
Total wages/salary Rs m7,4672,511 297.4%   
Avg. sales/employee Rs ThNM3,747.4-  
Avg. wages/employee Rs ThNM665.7-  
Avg. net profit/employee Rs ThNM367.8-  
INCOME DATA
Net Sales Rs m39,34714,135 278.4%  
Other income Rs m94366 25.6%   
Total revenues Rs m39,44114,501 272.0%   
Gross profit Rs m8,7362,178 401.0%  
Depreciation Rs m1,152570 202.3%   
Interest Rs m18435 527.5%   
Profit before tax Rs m7,4931,940 386.3%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,568552 283.8%   
Profit after tax Rs m5,8441,387 421.3%  
Gross profit margin %22.215.4 144.1%  
Effective tax rate %20.928.5 73.5%   
Net profit margin %14.99.8 151.3%  
BALANCE SHEET DATA
Current assets Rs m19,57710,470 187.0%   
Current liabilities Rs m14,8962,749 541.9%   
Net working cap to sales %11.954.6 21.8%  
Current ratio x1.33.8 34.5%  
Inventory Days Days9055 162.6%  
Debtors Days Days4578 58.4%  
Net fixed assets Rs m27,0975,811 466.3%   
Share capital Rs m377167 225.6%   
"Free" reserves Rs m26,81114,248 188.2%   
Net worth Rs m27,18814,416 188.6%   
Long term debt Rs m4,9930-   
Total assets Rs m47,77817,649 270.7%  
Interest coverage x41.756.6 73.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.8 102.8%   
Return on assets %12.68.1 156.6%  
Return on equity %21.59.6 223.4%  
Return on capital %23.613.7 172.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,4536,164 315.6%   
Fx outflow Rs m6,0651,334 454.5%   
Net fx Rs m13,3884,829 277.2%   
CASH FLOW
From Operations Rs m8,1201,231 659.9%  
From Investments Rs m-7,556-208 3,630.9%  
From Financial Activity Rs m590-595 -99.2%  
Net Cashflow Rs m1,153427 270.0%  

Share Holding

Indian Promoters % 74.1 55.4 133.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 2.9 3.4 85.5%  
FIIs % 9.1 3.9 233.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 37.0 37.6%  
Shareholders   49,328 30,437 162.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   SANOFI INDIA  ABBOTT INDIA  FRESENIUS KABI ONCO.  CIPLA  TORRENT PHARMA  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note for Third Straight Day; Yes Bank Falls 5%(Closing)

Indian share markets traded on a positive note most of the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views on News

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9% (Quarterly Result Update)

May 9, 2019 | Updated on May 9, 2019

For the quarter ended March 2019, ALEMBIC PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.6% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

A One Stock Crorepati(Profit Hunter)

Jul 4, 2019

Do you wish you could become a crorepati in the stock market? Read on...

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jul 17, 2019 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS